Momenta Pharmaceuticals (Momenta Pharmaceuticals) EV-to-EBIT : -26.38 (As of Apr. 26, 2024)

Momenta Pharmaceuticals EV-to-EBIT Chart

Momenta Pharmaceuticals Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19
EV-to-EBIT		Get a 7-Day Free Trial					-7.99	-9.92	-7.41	-3.51	-6.42

Momenta Pharmaceuticals Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
EV-to-EBIT	Get a 7-Day Free Trial															-4.70	-4.67	-6.42	-10.07	-15.71

Competitive Comparison of Momenta Pharmaceuticals's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Momenta Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Momenta Pharmaceuticals's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Momenta Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Momenta Pharmaceuticals's EV-to-EBIT falls into.

Momenta Pharmaceuticals EV-to-EBIT Calculation

Momenta Pharmaceuticals's EV-to-EBIT for today is calculated as:

Momenta Pharmaceuticals's current Enterprise Value is $5,844.09 Mil.
Momenta Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-221.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Momenta Pharmaceuticals  (NAS:MNTA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Momenta Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 is calculated as:

Momenta Pharmaceuticals's Enterprise Value for the quarter that ended in Jun. 2020 was $3,546.44 Mil.
Momenta Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-221.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Momenta Pharmaceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Momenta Pharmaceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Momenta Pharmaceuticals (Momenta Pharmaceuticals) Business Description